Interstitial Lung Disease Trial, Recruiting (NCT06197204)

Interstitial Lung Disease Trial, Recruiting NCT06197204 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Interstitial Lung Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06197204 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Interstitial Lung Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with LCH (Langerhans Cell Histiocytosis):

Adults aged 18 or older
People with a confirmed diagnosis of LCH who are seen at the reference centre, regardless of how the condition presents

For people in the control group:

Adults aged 18 or older
People who have been diagnosed with diffuse lung cystic disease, pulmonary emphysema, or who are healthy smokers

For all participants:

People who are willing and able to sign an informed consent form
People who have health insurance coverage

Who may not be able to join:

People who are under legal guardianship, curatorship, or whose freedom has been restricted by a court or government decision
People receiving State Medical Aid (AME)
Women who are pregnant, in labour, or currently breastfeeding
People who are receiving psychiatric care, or who are admitted to a health or social care facility for reasons unrelated to this research
People who are unable to give their own consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33142499618

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06197204

Sponsor: Assistance Publique - Hôpitaux de Paris

Phase: Not Applicable

Status: Recruiting

Condition: Interstitial Lung Disease

Trial contact: +33142499618

More information: https://clinicaltrials.gov/study/NCT06197204

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For people with LCH (Langerhans Cell Histiocytosis):

Adults aged 18 or older
People with a confirmed diagnosis of LCH who are seen at the reference centre, regardless of how the condition presents

For people in the control group:

Adults aged 18 or older
People who have been diagnosed with diffuse lung cystic disease, pulmonary emphysema, or who are healthy smokers

For all participants:

People who are willing and able to sign an informed consent form
People who have health insurance coverage

Who may not be able to join:

People who are under legal guardianship, curatorship, or whose freedom has been restricted by a court or government decision
People receiving State Medical Aid (AME)
Women who are pregnant, in labour, or currently breastfeeding
People who are receiving psychiatric care, or who are admitted to a health or social care facility for reasons unrelated to this research
People who are unable to give their own consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Assistance Publique - Hôpitaux de Paris

Registry

ClinicalTrials.gov

Start date

25 March 2024

Est. completion

25 March 2034

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Description of the clinical phenotype at diagnosis and the outcome of adult LCH patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov